Fungal cell membrane and cell wall

The fungal cell membrane and cell wall are essential structural components that distinguish fungi from mammalian cells, making them primary targets for antifungal therapy. The cell wall is a complex matrix of chitin, beta-glucans, and mannoproteins that provides mechanical strength and protects the cell from osmotic pressure (Source: NIH/NCBI, PMC5017208). The underlying plasma membrane is characterized by the presence of ergosterol, a sterol unique to fungi that maintains membrane fluidity and integrity (Source: StatPearls, NBK459322). Disrupting these structures—either by inhibiting the synthesis of key components like ergosterol and beta-glucan or by direct physical damage—leads to cell lysis and death. Polyenes like amphotericin B bind directly to ergosterol to create lethal pores, while azoles and allylamines inhibit the enzymes responsible for ergosterol biosynthesis (Source: PubMed, 30662362). Echinocandins disrupt the cell wall by inhibiting the synthesis of 1,3-beta-glucan, leading to osmotic instability. Because human cells lack a cell wall and utilize cholesterol instead of ergosterol, these structures offer a high degree of selective toxicity, although some cross-reactivity and off-target effects remain clinical challenges.

Other names

Fungal cell envelopeMycological cell wallFungal plasma membraneFungal cell boundary

Inhibition of ergosterol biosynthesis (via 14-alpha-demethylase or squalene epoxidase inhibition), direct binding to ergosterol to create transmembrane pores, and inhibition of 1,3-beta-D-glucan synthesis.